Valuation: Unichem Laboratories Limited

Market Cap 3.87TCr 40Cr 35Cr 33Cr 31Cr 57Cr 58Cr 400.83Cr 155.25Cr 1.98TCr 151.75Cr 148.47Cr 6.36TCr P/E 2025
35.6x
P/E 2026 8.19x
Enterprise Value 4.08TCr 43Cr 37Cr 35Cr 32Cr 60Cr 61Cr 422.63Cr 163.69Cr 2.09TCr 160Cr 156.54Cr 6.71TCr EV / Sales 2025
2.49x
EV / Sales 2026 1.03x
Free-Float
28.74%
Yield 2025 *
-
Yield 2026 -
1 day-0.53%
1 week+0.73%
Current month-1.23%
1 month+4.50%
3 months+26.95%
6 months+84.03%
Current year+24.41%
1 week 521.55
Extreme 521.55
582
1 month 497.8
Extreme 497.8
591.25
Current year 278.2
Extreme 278.2
687.2
1 year 278.2
Extreme 278.2
687.2
3 years 278.2
Extreme 278.2
937.95
5 years 198
Extreme 198
937.95
10 years 80
Extreme 80
937.95
Manager TitleAgeSince
Chief Executive Officer 57 10/08/2023
Director of Finance/CFO - 08/08/2024
Compliance Officer - -
Director TitleAgeSince
Chairman 73 22/08/1977
Director/Board Member 53 10/08/2023
Director/Board Member 57 10/08/2023
Change 5-day change 1-year change 3-year change Capi.($)
-0.53%+0.73% - - 40Cr
+0.13%+2.65%+65.61%+114.28% 1,05500Cr
+0.20%+0.46%+52.60%+69.24% 65TCr
-0.29%+0.14%+20.96%+70.93% 47TCr
-0.85%+0.98%+41.29%+44.38% 35TCr
+0.71%+4.08%+22.24%+29.51% 27TCr
+1.23%+0.42%+14.57%+12.13% 26TCr
+2.11%+7.51%+52.89%+55.37% 22TCr
+0.83%+0.55%+35.99%+101.70% 19TCr
0.00%-10.14%-29.94%-60.30% 17TCr
Average +0.27%+0.74%+30.69%+48.58% 40.43TCr
Weighted average by Cap. +0.02%+1.32%+41.54%+67.83%

Financials

2025 2026
Net sales 2.11TCr 22Cr 19Cr 18Cr 17Cr 31Cr 31Cr 218.43Cr 85Cr 1.08TCr 83Cr 81Cr 3.47TCr 2.2TCr 23Cr 20Cr 19Cr 17Cr 32Cr 33Cr 227.83Cr 88Cr 1.12TCr 86Cr 84Cr 3.62TCr
Net income 137.52Cr 1.43Cr 1.26Cr 1.19Cr 1.08Cr 2.03Cr 2.04Cr 14Cr 5.51Cr 70Cr 5.39Cr 5.27Cr 225.8Cr 252.84Cr 2.64Cr 2.31Cr 2.19Cr 1.99Cr 3.73Cr 3.76Cr 26Cr 10Cr 129.17Cr 9.9Cr 9.69Cr 415.14Cr
Net Debt 370.19Cr 3.86Cr 3.39Cr 3.2Cr 2.92Cr 5.46Cr 5.5Cr 38Cr 15Cr 189.12Cr 15Cr 14Cr 607.82Cr 210.67Cr 2.2Cr 1.93Cr 1.82Cr 1.66Cr 3.11Cr 3.13Cr 22Cr 8.44Cr 107.63Cr 8.25Cr 8.07Cr 345.9Cr
Logo Unichem Laboratories Limited
Unichem Laboratories Limited is an India-based international, integrated, specialty pharmaceutical company. The Company is focused on product development, process chemistry and manufacturing complex active pharmaceutical ingredients (API) as well as dosage forms. It manufactures and markets pharmaceutical formulations as branded generics as well as generics in several markets across the world. It has several pharma products that address the needs of various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. The Company is also engaged in contract manufacturing with the focus on immediate-release dosage forms, extended-release dosage forms: matrix and pellets, dry powder injections and syrups, novel drug delivery systems, and technology transfer and documentation. Its subsidiaries include Unichem Pharmaceuticals (USA) Inc, Unichem Farmaceutica Do Brasil Lta and Niche Generics Limited UK.
Employees
2,780
Date Price Change Volume
25/26/25 ₹549.70 -0.53% 50,490
24/26/24 ₹552.65 -3.59% 1,56,065
23/26/23 ₹573.20 +6.39% 2,94,887
22/26/22 ₹538.75 -0.35% 1,14,861
21/26/21 ₹540.65 -0.93% 72,661